Literature DB >> 23095808

Cross-sectional association between polyfluoroalkyl chemicals and cognitive limitation in the National Health and Nutrition Examination Survey.

Melinda C Power1, Thomas F Webster, Andrea A Baccarelli, Marc G Weisskopf.   

Abstract

BACKGROUND/AIMS: Our limited understanding of how polyfluoroalkyl chemicals (PFCs) may impact on human health suggests the potential for a protective impact on brain health. This study was designed to explore the association between PFCs and cognitive ability in older adults.
METHODS: We assessed the association between four PFCs, perfluorooctanoic acid (PFOA), perfluorooctane sulfonic acid (PFOS), perfluorononanoic acid (PFNA) and perfluorohexane sulfonic acid (PFHxS), and self-reported limitation due to difficulty remembering or periods of confusion using data from participants aged 60-85 years from the 1999-2000 and 2003-2008 National Health and Nutrition Examination Surveys. We also considered whether diabetic status or diabetic medication use modifies this association in light of in vitro evidence that PFCs may act on the same receptors as some diabetic medications.
RESULTS: In multivariable adjusted models, point estimates suggest a protective association between PFCs and self-reported cognitive limitation (odds ratio, OR; 95% confidence interval, CI) for a doubling in PFC concentration: PFOS (OR, 0.90; 95% CI, 0.78, 1.03), PFOA (OR, 0.92; 95% CI, 0.78, 1.09), PFNA (OR, 0.91; 95% CI, 0.79, 1.04) and PFHxS (OR, 0.93; 95% CI, 0.82, 1.06). The protective association was concentrated in diabetics, with strong, significant protective associations in nonmedicated diabetics.
CONCLUSIONS: This cross-sectional study suggests that there may be a protective association between exposure to PFCs and cognition in older adults, particularly diabetics.
Copyright © 2012 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23095808      PMCID: PMC3658136          DOI: 10.1159/000342310

Source DB:  PubMed          Journal:  Neuroepidemiology        ISSN: 0251-5350            Impact factor:   3.282


  34 in total

1.  Differential activation of nuclear receptors by perfluorinated fatty acid analogs and natural fatty acids: a comparison of human, mouse, and rat peroxisome proliferator-activated receptor-alpha, -beta, and -gamma, liver X receptor-beta, and retinoid X receptor-alpha.

Authors:  John P Vanden Heuvel; Jerry T Thompson; Steven R Frame; Peter J Gillies
Journal:  Toxicol Sci       Date:  2006-05-26       Impact factor: 4.849

2.  Activation of mouse and human peroxisome proliferator-activated receptors (alpha, beta/delta, gamma) by perfluorooctanoic acid and perfluorooctane sulfonate.

Authors:  Margy L Takacs; Barbara D Abbott
Journal:  Toxicol Sci       Date:  2006-10-17       Impact factor: 4.849

3.  Effects of perfluorooctane sulfonate on action potentials and currents in cultured rat cerebellar Purkinje cells.

Authors:  Kouji H Harada; Takahiro M Ishii; Kenji Takatsuka; Akio Koizumi; Harunori Ohmori
Journal:  Biochem Biophys Res Commun       Date:  2006-10-23       Impact factor: 3.575

4.  Preserved cognition in patients with early Alzheimer disease and amnestic mild cognitive impairment during treatment with rosiglitazone: a preliminary study.

Authors:  G Stennis Watson; Brenna A Cholerton; Mark A Reger; Laura D Baker; Stephen R Plymate; Sanjay Asthana; Mark A Fishel; J Jacob Kulstad; Pattie S Green; David G Cook; Steven E Kahn; Michelle L Keeling; Suzanne Craft
Journal:  Am J Geriatr Psychiatry       Date:  2005-11       Impact factor: 4.105

5.  Efficacy of rosiglitazone in a genetically defined population with mild-to-moderate Alzheimer's disease.

Authors:  M E Risner; A M Saunders; J F B Altman; G C Ormandy; S Craft; I M Foley; M E Zvartau-Hind; D A Hosford; A D Roses
Journal:  Pharmacogenomics J       Date:  2006-01-31       Impact factor: 3.550

Review 6.  Mild cognitive impairment--beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment.

Authors:  B Winblad; K Palmer; M Kivipelto; V Jelic; L Fratiglioni; L-O Wahlund; A Nordberg; L Bäckman; M Albert; O Almkvist; H Arai; H Basun; K Blennow; M de Leon; C DeCarli; T Erkinjuntti; E Giacobini; C Graff; J Hardy; C Jack; A Jorm; K Ritchie; C van Duijn; P Visser; R C Petersen
Journal:  J Intern Med       Date:  2004-09       Impact factor: 8.989

Review 7.  Perfluoroalkyl acids: a review of monitoring and toxicological findings.

Authors:  Christopher Lau; Katherine Anitole; Colette Hodes; David Lai; Andrea Pfahles-Hutchens; Jennifer Seed
Journal:  Toxicol Sci       Date:  2007-05-22       Impact factor: 4.849

8.  Neuroendocrine effects of perfluorooctane sulfonate in rats.

Authors:  Maureen E Austin; Badrinarayanan S Kasturi; Matthew Barber; Kurunthachalam Kannan; Puliyur S MohanKumar; Sheba M J MohanKumar
Journal:  Environ Health Perspect       Date:  2003-09       Impact factor: 9.031

9.  Half-life of serum elimination of perfluorooctanesulfonate,perfluorohexanesulfonate, and perfluorooctanoate in retired fluorochemical production workers.

Authors:  Geary W Olsen; Jean M Burris; David J Ehresman; John W Froehlich; Andrew M Seacat; John L Butenhoff; Larry R Zobel
Journal:  Environ Health Perspect       Date:  2007-09       Impact factor: 9.031

10.  Polyfluoroalkyl chemicals in the U.S. population: data from the National Health and Nutrition Examination Survey (NHANES) 2003-2004 and comparisons with NHANES 1999-2000.

Authors:  Antonia M Calafat; Lee-Yang Wong; Zsuzsanna Kuklenyik; John A Reidy; Larry L Needham
Journal:  Environ Health Perspect       Date:  2007-11       Impact factor: 9.031

View more
  14 in total

1.  Prenatal and childhood exposure to per- and polyfluoroalkyl substances (PFASs) and child cognition.

Authors:  Maria H Harris; Emily Oken; Sheryl L Rifas-Shiman; Antonia M Calafat; Xiaoyun Ye; David C Bellinger; Thomas F Webster; Roberta F White; Sharon K Sagiv
Journal:  Environ Int       Date:  2018-04-26       Impact factor: 9.621

2.  Circulating levels of perfluoroalkyl substances and prevalent diabetes in the elderly.

Authors:  Lars Lind; Björn Zethelius; Samira Salihovic; Bert van Bavel; P Monica Lind
Journal:  Diabetologia       Date:  2013-12-14       Impact factor: 10.122

3.  The association between prenatal exposure to perfluoroalkyl substances and childhood neurodevelopment.

Authors:  Miranda J Spratlen; Frederica P Perera; Sally Ann Lederman; Virginia A Rauh; Morgan Robinson; Kurunthachalam Kannan; Leonardo Trasande; Julie Herbstman
Journal:  Environ Pollut       Date:  2020-03-26       Impact factor: 8.071

4.  Perfluorooctanoate exposure in a highly exposed community and parent and teacher reports of behaviour in 6-12-year-old children.

Authors:  Cheryl R Stein; David A Savitz; David C Bellinger
Journal:  Paediatr Perinat Epidemiol       Date:  2013-12-09       Impact factor: 3.980

5.  Perfluorooctanoate and neuropsychological outcomes in children.

Authors:  Cheryl R Stein; David A Savitz; David C Bellinger
Journal:  Epidemiology       Date:  2013-07       Impact factor: 4.822

6.  Exposure to environmental chemical mixtures is associated with nasal colonization by Staphylococcus aureus: NHANES 2001-2004.

Authors:  Shoshannah Eggers; Chris Gennings; Kristen M C Malecki; Nasia Safdar; Manish Arora
Journal:  Environ Res       Date:  2020-07-29       Impact factor: 6.498

7.  Perfluoroalkyl substances and cognitive function in older adults: Should we consider non-monotonic dose-responses and chronic kidney disease?

Authors:  Sung Kyun Park; Ning Ding; Dehua Han
Journal:  Environ Res       Date:  2020-10-15       Impact factor: 6.498

8.  Serum perfluoroalkyl acids concentrations and memory impairment in a large cross-sectional study.

Authors:  Valentina Gallo; Giovanni Leonardi; Carol Brayne; Ben Armstrong; Tony Fletcher
Journal:  BMJ Open       Date:  2013-06-20       Impact factor: 2.692

9.  Gastrointestinal Elimination of Perfluorinated Compounds Using Cholestyramine and Chlorella pyrenoidosa.

Authors:  Stephen J Genuis; Luke Curtis; Detlef Birkholz
Journal:  ISRN Toxicol       Date:  2013-09-09

10.  Gestational exposure to endocrine-disrupting chemicals and reciprocal social, repetitive, and stereotypic behaviors in 4- and 5-year-old children: the HOME study.

Authors:  Joseph M Braun; Amy E Kalkbrenner; Allan C Just; Kimberly Yolton; Antonia M Calafat; Andreas Sjödin; Russ Hauser; Glenys M Webster; Aimin Chen; Bruce P Lanphear
Journal:  Environ Health Perspect       Date:  2014-03-12       Impact factor: 9.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.